Skip to main content
. 2021 Oct;12(5):2157–2171. doi: 10.21037/jgo-21-494

Table 1. Clinicopathological information of the three COAD patient cohorts in this study.

Covariates Type Total Testing Training P value
Age ≤65 183 93 90 0.786
>65 263 129 134
Gender Female 212 104 108 0.8459
Male 234 118 116
Stage Stage I–II 250 126 124 0.7071
Stage III–IV 185 89 96
Unknown 11 7 4
T T1–2 86 47 39 0.3878
T3–4 359 175 184
Unknown 1 0 1
M M0 329 161 168 1
M1 61 30 31
Unknown 56 31 25
N N0 265 134 131 0.7585
N1–2 181 88 93

COAD, colon adenocarcinoma.